Ligand profile
O3Y
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00363 — LpxA-like domain-containing transferase
Identifiers
Database identifiers and provenance.
- Ligand ID
O3Y- PDB
6p83- UniProt (similar protein)
P21645- Target protein
- KP13_00363
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 68.0
- −1 ≤ LogP ≤ 5 5.60
- MW ≤ 500 Da 417.9
- LogP ≤ 5 5.60
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 68.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC1(Cc2c(c(c3c(n2)nn(c3O)c4ccccc4)c5ccccc5Cl)C(=O)C1)CCC1(Cc2c(c(c3c(n2)nn(c3O)c4ccccc4)c5ccccc5Cl)C(=O)C1)C
InChI=1S/C24H20ClN3O2/c1-24(2)12-17-20(18(29)13-24)19(15-10-6-7-11-16(15)25)21-22(26-17)27-28(23(21)30)14-8-4-3-5-9-14/h3-11,30H,12-13H2,1-2H3InChI=1S/C24H20ClN3O2/c1-24(2)12-17-20(18(29)13-24)19(15-10-6-7-11-16(15)25)21-22(26-17)27-28(23(21)30)14-8-4-3-5-9-14/h3-11,30H,12-13H2,1-2H3
RZRIAROHONSNNR-UHFFFAOYSA-NRZRIAROHONSNNR-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00132' 'PF04613
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand O3Y →
- PDB RCSB structure 6p83 →
- UniProt UniProt P21645 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “O3Y”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00363.
PDB 15
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).